These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 5487694

  • 1. [Metabolism of triiodothyronine in hyperthyroidism and in myxedema].
    Zaninovich AA, Degrossi O, Pecorini V.
    Medicina (B Aires); 1970; 30(4):380-3. PubMed ID: 5487694
    [No Abstract] [Full Text] [Related]

  • 2. [Relationship between triiodothyronine kinetics and metabolic changes. II].
    Zaninovich A, Degrossi O, Pecorini V, Gotta H.
    Medicina (B Aires); 1969; 29(4):259-62. PubMed ID: 5382839
    [No Abstract] [Full Text] [Related]

  • 3. Lack of significant binding of L-triiodothyronine by thyroxine-binding globulin in vivo as demonstrated by acute disappearance of 131-I-labeled triiodothyronine.
    Zaninovich AA, Farach H, Ezrin C, Volpé R.
    J Clin Invest; 1966 Aug; 45(8):1290-301. PubMed ID: 4958993
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic clearance rate and production rate of thyroid-stimulating hormone in man.
    Beckers C, Machiels J, Soyez C, Cornette C.
    Horm Metab Res; 1971 Jan; 3(1):34-6. PubMed ID: 5128326
    [No Abstract] [Full Text] [Related]

  • 5. [Parallel study of thyroxine and triiodo-thyronine metabolism in diabetics].
    Jaffiol C, Pastorello R, Cartry E, Mirouze J.
    Ann Endocrinol (Paris); 1966 Jan; 27(6):703-18. PubMed ID: 4166140
    [No Abstract] [Full Text] [Related]

  • 6. Renal function and I131 clearance in hyperthyroidism and myxedema.
    HLAD CJ, BRICKER NS.
    J Clin Endocrinol Metab; 1954 Dec; 14(12):1539-50. PubMed ID: 13211789
    [No Abstract] [Full Text] [Related]

  • 7. Goitrous myxedema with defect in iodide trapping and hormonogenesis.
    Gilboa Y, Ber A, Lewitus Z, Lubin E, Gordon A, Stein O.
    Isr J Med Sci; 1966 Dec; 2(2):145-51. PubMed ID: 5912549
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The metabolism of iodothyronines in health and disease with special reference to diiodothyronines.
    Faber J.
    Dan Med Bull; 1984 Aug; 31(4):257-70. PubMed ID: 6383736
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of serum cholesterol reduction by thyroid hormones in hypothyroidism.
    Miettinen TA.
    J Lab Clin Med; 1968 Apr; 71(4):537-47. PubMed ID: 5651359
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease.
    STERLING K, CHODOS RB.
    J Clin Invest; 1956 Jul; 35(7):806-13. PubMed ID: 13332064
    [No Abstract] [Full Text] [Related]

  • 13. Some effects of magnesium loading in patients with thyroid disorders.
    WISWELL JG.
    J Clin Endocrinol Metab; 1961 Jan; 21():31-8. PubMed ID: 13786043
    [No Abstract] [Full Text] [Related]

  • 14. Metabolic clearance rate of L-triiodothyronine in man: a comparison of results by single-injection and constant infusion methods.
    Cavalieri RR, Steinberg M, Searle GL.
    J Clin Endocrinol Metab; 1971 Oct; 33(4):624-9. PubMed ID: 4106087
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic effects of intravenous triiodothyroacetic acid in primary myxedema.
    DE GRAEFF J, QUERIDO A, WICHT CL.
    J Clin Endocrinol Metab; 1957 Feb; 17(2):328-30. PubMed ID: 13398475
    [No Abstract] [Full Text] [Related]

  • 16. Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus.
    Owens D, Srivastava MC, Tompkins CV, Nabarro JD, Sönksen PH.
    Eur J Clin Invest; 1973 Jul; 3(4):284-94. PubMed ID: 4760050
    [No Abstract] [Full Text] [Related]

  • 17. [Study of some urinary metabolites of catecholamines in thyroid insufficiency].
    Chivu V, Bălan M, Stancu H, Muşeţeanu P.
    Stud Cercet Endocrinol; 1969 Jul; 20(4):357-61. PubMed ID: 5374126
    [No Abstract] [Full Text] [Related]

  • 18. [Pretibial myxedema 3 years after treatment of hyperthyroidism by iodine 131].
    Many P, Lapeyre J, Teillard J, Chabeau G.
    Bull Soc Fr Dermatol Syphiligr; 1968 Jul; 75(3):290. PubMed ID: 5723912
    [No Abstract] [Full Text] [Related]

  • 19. 1-Triiodothyronine versus 1-throxine; a comparison of their metabolic effects in human myxedema.
    RAWSON RV, RALL JE, PEARSON OH, ROBBINS J, POPPELL HF, WEST CD.
    Am J Med Sci; 1953 Oct; 226(4):405-11. PubMed ID: 13092101
    [No Abstract] [Full Text] [Related]

  • 20. [Radiochromatographic analysis of the subhepatic and peripheral blood, of the bile and urine, at successive stages after administration of labeled 3,5,3-triiodo-L-thyronine to an athyroid myxedematous patient].
    TURPIN R, ROCHE J, TRITTO C, MICHEL R, CRUVEILLER J.
    Rev Fr Etud Clin Biol; 1960 May; 5():485-90. PubMed ID: 13839986
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.